Sueda Taijiro, Orihashi Kazumasa, Okada Kenji, Sugawara Yuji, Imai Katsuhiko, Kochi Kazuhiro
Department of Cardiovascular Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Ann Thorac Surg. 2003 Jul;76(1):84-9; discussion 89. doi: 10.1016/s0003-4975(03)00266-2.
The purpose of this study was to evaluate the midterm results of transaortic stent-grafting for distal aortic arch aneurysms or proximal descending aortic aneurysms and the feasibility of this method for thoracic aortic aneurysm repair.
Twenty-three patients with true distal aortic arch aneurysms or proximal descending thoracic aortic aneurysms were repaired with the stent-graft introduced through the incision on the proximal arch aorta. Follow-up computed tomography was performed every 6 months in 21 surviving patients. The maximum dimension of the excluded aneurysmal space and the maximum aneurysmal diameter were measured and evaluated to determine whether the aneurysmal space decreased or disappeared after this alternative procedure.
There was 1 hospital death (4.3%) due to cerebral embolism. Another patient died of pneumonia 1 year after surgery. Twenty-one patients (91%) survived during the follow-up period, but 1 patient (4.3%) suffered from paraplegia. The follow-up period ranged from 12 to 62 months (average, 34.3 +/- 15.2). There were no instances of aneurysmal rupture during the follow-up period. Postoperative serial computed tomography scans showed disappearance or significant shrinkage of the excluded aneurysmal space in 20 of 21 patients (95%), except for the one patient with endoluminal leakage.
Transaortic endovascular stent-grafting was an effective alternative approach to treating distal aortic arch aneurysms or proximal descending aortic aneurysms. The excluded aneurysm disappeared or shrunk after successful placement of the stent-graft.
本研究的目的是评估经主动脉植入支架型人工血管治疗主动脉弓远端动脉瘤或降主动脉近端动脉瘤的中期结果,以及该方法用于胸主动脉瘤修复的可行性。
23例主动脉弓远端真性动脉瘤或降主动脉近端真性动脉瘤患者通过在主动脉弓近端做切口植入支架型人工血管进行修复。21例存活患者每6个月进行一次随访CT检查。测量并评估被隔绝动脉瘤腔的最大尺寸和动脉瘤最大直径,以确定在采用这种替代方法后动脉瘤腔是否缩小或消失。
1例患者因脑栓塞在医院死亡(4.3%)。另1例患者术后1年死于肺炎。21例患者(91%)在随访期内存活,但1例患者(4.3%)发生截瘫。随访期为从12至62个月(平均34.3±15.2个月)。随访期间无动脉瘤破裂情况发生。术后系列CT扫描显示21例患者中有20例(95%)被隔绝的动脉瘤腔消失或显著缩小,除了1例发生腔内漏血的患者。
经主动脉血管腔内植入支架型人工血管是治疗主动脉弓远端动脉瘤或降主动脉近端动脉瘤的一种有效替代方法。成功植入支架型人工血管后,被隔绝动脉瘤消失或缩小。